Prevention of Anal Cancer in HIV-Positive Men and Women: An Evolving Landscape
Joel M. Palefsky, MD, FRCP(C)
Professor of Medicine, Division of infectious Diseases
UCSF School of Medicine, San Francisco, CA
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2018. All rights reserved.
Joel Palefsky is Professor of Medicine at the University of California San Francisco. A native of Montreal, Dr. Palefsky graduated from the McGill University School of Medicine. He trained in internal medicine at McGill University and infectious diseases at Stanford University. He founded and directs the world's first clinic devoted to prevention of anal cancer, the UCSF Anal Neoplasia Clinic Research and Education Center. He is the founding president of the International Anal Neoplasia Society and immediate past president of the International Papillomavirus Society. Dr. Palefsky has published extensively on natural history and molecular pathogenesis of HPV infection particularly in the setting of HIV infection, and his laboratory is currently focused on development of targeted molecular approaches to treatment of HPV-associated disease. He is the protocol chair of the ANCHOR study and is the author of over 350 publications.
At the completion of this educational session, learners will:
- Understand how the epidemiology of anal cancer, pre-cancer and HPV infection in HIV-positive individuals is changing.
- Know current methods for the prevention of anal cancer in HIV-positive individuals.
- Be aware of the rationale for, and current status of, the Anal Cancer/HSIL Outcomes Research (ANCHOR) study.
This CME activity was approved for AMA PRA Category 1 Credit™
on September 11, 2018 and will terminate September 10, 2021.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Joel M. Palefsky (Presenter) had the following personal financial relationships in the prior 12 months with manufacturers of the products or services that may be presented in this CME activity: Research support from Antiva, and Merck; Consultant to Agenovir, Novan, Vaccitech, and Virion; Stock options on Agenovir, and Ubiome; Speaker for Janssen. Dr. Palefsky submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; and Merck & Co.
To obtain CME credit for this PRN program, please visit the PRN Courses Page
at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.